Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia

Psychosomatics

Volumn 51, Issue 6, 2010, Pages 489-497

  Arnold, Lesley M ^a   Leon, Teresa ^b   Whalen, Ed ^b   Barrett, Jeannette ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREGABALIN;

ANALGESIA; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; FIBROMYALGIA; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MONOTHERAPY; MOOD; TREATMENT OUTCOME;

EID: 78649663431     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1176/appi.psy.51.6.489     Document Type: Article

References (30)

1. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-172
2. Wolfe F, Ross K, Anderson J, et al: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38:19-28
3. Mease P, Arnold LM, Bennett R, et al: Fibromyalgia syndrome. J Rheumatol 2007; 34:1415-1425
4. White KP, Nielson WR, Harth M, et al: Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 2002; 29:588-594
5. Epstein SA, Kay G, Clauw D, et al: Psychiatric disorders in patients with fibromyalgia. Psychosomatics 1999; 40:57-63
6. Malt EA, Berle JE, Olafsson S, et al: Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders: a study of women with random sample population controls. J Psychosom Res 2000; 49:285-289 (Pubitemid 32123804)
7. Hudson JI, Goldenberg DL, Pope HG Jr, et al: Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92:363-367
8. Walker EA, Keegan D, Gardner G, et al: Psychosocial factors in fibromyalgia compared with rheumatoid arthritis, I: psychiatric diagnoses and functional disability. Psychosom Med 1997; 59:565-571
9. Turk DC, Rudy TE: Toward a comprehensive assessment of chronic pain patients. Behav Res Ther 1987; 25:237-249
10. Dooley DJ, Taylor CP, Donevan S, et al: Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol Sci 2007; 28:75-82
11. Taylor CP, Angelotti T, Fauman E: Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007; 73:137-150
12. Crofford LJ, Rowbotham MC, Mease PJ, Pregabalin 1008-105 Study Group, et al: Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52:1264-1273
13. Mease PJ, Russell IJ, Arnold LM, et al: A randomized, double-blind, placebo-controlled, Phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008; 35:502-514
14. Arnold LM, Russell IJ, Diri EW, et al: A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008; 9:792-805
15. Crofford LJ, Mease PJ, Simpson SL, et al: Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin: Pain 2008; 136:419-431
16. FDA News. P07-107. June 21, 2007; http://www.fda.gov/bbs/topics/NEWS/ 2007/NEW01656.html
17. Arnold LM, Crofford LJ, Martin SA, et al: The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med 2007; 8:633-638
18. Zigmond A, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67:361-370
19. Snaith RP, Zigmond AS: The Hospital Anxiety and Depression Scale Manual. London, UK, NFER Nelson, 1994
20. Arnold LM, Crofford LJ, Mease PJ, et al: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 2008; 73:114-120
21. Arnold LM, Hudson JI, Hess EV, et al: Family study of fibromyalgia. Arthritis Rheum 2004; 50:944-952
22. Hudson JI, Arnold LM, Keck PE Jr, et al: Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004; 56:884-891
23. Raphael KG, Janal MN, Nayak S, et al: Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 2004; 110:449-460
24. Feltner DE, Crockatt JG, Dubovsky SJ, et al: A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003; 23:240-249
25. Pohl RB, Feltner DE, Fieve RR, et al: Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of bid versus tid dosing. J Clin Psychopharmacol 2005; 25:151-158
26. Rickels K, Pollack MH, Feltner DE, et al: Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry 2005; 62:1022-1030
27. Montgomery SA, Tobias K, Zornberg GL, et al: Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry 2006; 67:771-782
28. Montgomery S, Chatamra K, Pauer L, et al: Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 2008; 193:389-394
29. Feltner D, Wittchen HU, Kavoussi R, et al: Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol 2008; 23:18-28
30. Kasper S, Herman B, Nivoli G, et al: Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled, 8-week trial. Int Clin Psychopharmacol 2009; 24:87-96